Teoxane Laboratories Geneva
Teoxane Laboratories Geneva is a Swiss medical aesthetics company founded in 2003 that designs, manufactures, and globally commercializes hyaluronic acid dermal fillers (TEOSYAL, RHA) and dermocosmetics, selling primarily to licensed healthcare professionals across 90+ countries via subsidiaries and distribution partners.
- Company typePrivate
- Founded2003
- HeadquartersGeneva, Switzerland
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Teoxane Laboratories Geneva does
Teoxane Laboratories Geneva (TEOXANE SA) is a Swiss medical aesthetics company founded in 2003 by Valérie Taupin in Geneva, specializing in the design, manufacture, and global commercialization of hyaluronic acid (HA)-based dermal fillers and dermocosmetics. The company operates through two principal product lines — the TEOSYAL PureSense range (with lidocaine for patient comfort, spanning indications from skin rehydration to volume restoration) and the TEOSYAL RHA (Resilient Hyaluronic Acid) collection, which is engineered to adapt to dynamic facial movement. Dermal fillers are regulated as Class III medical devices and complemented by a dermocosmetics range that includes the RHA Deep Repair Balm and the integrated R-Energy skin quality system.
The company's underlying technology centers on its proprietary RHA formulation and rheology work, supported by peer-reviewed clinical evidence and a dedicated R&D function in Geneva. Beyond injectables, Teoxane has developed proprietary injection protocols — notably the ATP framework and the MLT 3.1 (MultiLayering Technique) — which are taught through the Teoxane Global Academy. The product portfolio is sold under a hybrid go-to-market model: a B2B enterprise channel targeting licensed healthcare professionals (dermatologists, plastic surgeons, aesthetic physicians) via 10 wholly-owned subsidiaries and a network of international distributors, supplemented by a direct-to-consumer e-commerce channel for dermocosmetics. Revance Therapeutics holds exclusive US distribution rights for the RHA product line, and Teoxane secures FDA approvals as a core regulatory pillar of US market access.
Teoxane serves healthcare professionals in over 90 countries, with a workforce of 251–500 employees drawn from 30 nationalities and a subsidiary footprint spanning France, Italy, Germany, the UK, Spain, Poland, Switzerland, Singapore, Australia, the United States, and Dubai (META). Revenue is generated through one-time product sales of injectable medical devices and consumer skincare, with pricing quote-based and negotiated through subsidiary sales teams and distribution partners rather than publicly listed. The company remains privately held, founder-led, and independent of external private equity or venture capital, with no public listing disclosed in source materials.
Teoxane Laboratories Geneva firmographics
Firmographics- Name
- Teoxane Laboratories Geneva
- Legal name
- TEOXANE SA
- Website
- https://teoxane.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Teoxane Laboratories Geneva is a Swiss medical aesthetics company founded in 2003 that designs, manufactures, and globally commercializes hyaluronic acid dermal fillers (TEOSYAL, RHA) and dermocosmetics, selling primarily to licensed healthcare professionals across 90+ countries via subsidiaries and distribution partners.
- Ownership category
- akta.pro rank
Teoxane Laboratories Geneva industry classification
Industry- Product category
- Medical Aesthetics
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industry
- Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)
Keywords
Where Teoxane Laboratories Geneva is headquartered
LocationHeadquarters
- HQ city
- Geneva
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Teoxane Laboratories Geneva business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Dermal Filler Product Sales: Sale of HA-based dermal filler products to healthcare professionals and clinics. Products are sold as medical devices requiring professional administration.
- Dermocosmetics Sales: Sale of dermocosmetics (skincare) products directly to consumers through e-commerce and to healthcare professionals for patient recommendations.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Teoxane Laboratories Geneva product offering
Product offeringCore offering
Teoxane designs, manufactures, and globally distributes a complete range of hyaluronic acid (HA) dermal fillers under the TEOSYAL PureSense and TEOSYAL RHA product lines, sold as Class III medical devices exclusively to licensed healthcare professionals for facial rejuvenation, wrinkle correction, and volume restoration. The portfolio is complemented by a dermocosmetics skincare range (including RHA Deep Repair Balm and the R-Energy skin quality system) sold both to professionals for patient recommendations and directly to end consumers via the company's e-commerce platform.
Product overview
Teoxane Laboratories Geneva offers a comprehensive portfolio of hyaluronic acid-based aesthetic solutions, consisting of two main dermal filler lines (TEOSYAL PureSense and TEOSYAL RHA) and dermocosmetics. The TEOSYAL PureSense line includes Redensity 1 (skin booster), Redensity 2 (under-eye treatment), Global Action, Deep Lines, Kiss (lip filler), Ultra Deep, and Ultimate - all containing 0.3% lidocaine for patient comfort. The TEOSYAL RHA (Resilient Hyaluronic Acid) line comprises RHA 1, RHA 2, RHA 3, RHA 4, RHA Kiss, and RHA Kiss VolumeLIDO, designed to adapt to facial movements for natural-looking results. The portfolio is complemented by dermocosmetics including RHA Deep Repair Balm and the R-Energy skin quality system that combines injectables with topical skincare. The company also developed proprietary injection techniques including the ATP (Assessment & Anatomy, Techniques, Products) approach and MLT (MultiLayering Technique) 3.1.
Differentiator
Problem solved
Functional benefit
Brands
- TEOSYAL: Brand name for Teoxane's range of hyaluronic acid dermal fillers, including PureSense and RHA product lines.
- RHA (Resilient Hyaluronic Acid)
- TEOSYAL PureSense
- Teoxane Global Academy
Products and services
- TEOSYAL PureSense Redensity 1 Hyaluronic acid skin booster (15 mg/mL) with 0.3% lidocaine for skin rehydration, wrinkle improvement, and correction of skin ageing signs on the face, crow's feet, neck, and neckline. For use by licensed healthcare professionals.
- TEOSYAL PureSense Redensity 2 Hyaluronic acid filler with lidocaine for correction of fine lines and wrinkles and treatment of under-eye circles including the tear trough area. Expected lifetime of at least 12 months. For use by licensed healthcare professionals.
- TEOSYAL PureSense Global Action Dermal filler with lidocaine for correction of moderate wrinkles and cutaneous depressions. Creates volume that corrects wrinkles and enhances contour. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL PureSense Deep Lines Dermal filler with lidocaine for correction of deep wrinkles and cutaneous depressions. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL PureSense Kiss Lip filler with 0.3% lidocaine for restoration of lip volume and correction of cutaneous depressions around the mouth. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL PureSense Ultra Deep High-concentration hyaluronic acid filler (25 mg/mL) with lidocaine for facial contour remodelling, volume restoration and augmentation, and correction of deep wrinkles and folds in thick skin areas. Expected lifetime of 15 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL PureSense Ultimate Dermal filler with lidocaine for creation of volume that corrects cutaneous depressions or facial contours. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL RHA 1 Resilient hyaluronic acid filler for correction of fine lines including perioral rhytids, upper lip border, and philtrum. Expected lifetime of at least 12 months. For use by licensed healthcare professionals.
- TEOSYAL RHA 2 Resilient hyaluronic acid filler (23 mg/mL HA) with 0.3% lidocaine for filling linear facial wrinkles and skin creases such as mild to moderate nasolabial folds. Designed to adapt to facial dynamics. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL RHA 3 Resilient hyaluronic acid filler for filling deep facial wrinkles such as moderate to severe nasolabial folds, and FDA-authorized for lip augmentation. Designed to adapt to facial movements. Expected lifetime of 12 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL RHA 4 Resilient hyaluronic acid filler for filling deep wrinkles and folds in thick skin areas such as moderate to severe nasolabial folds and cheek augmentation. FDA-approved with Mepivacaine for midface augmentation. Expected lifetime of 15 to 18 months. For use by licensed healthcare professionals.
- TEOSYAL RHA Kiss VolumeLIDO Lip filler with lidocaine in the RHA collection for correction of moderate to severe dynamic facial wrinkles and folds, lip augmentation, and lip fullness. Expected lifetime of 12 months. For use by licensed healthcare professionals.
- TEOSYAL RHA Dynamic Volume New generation resilient hyaluronic acid filler for cheek augmentation and correction of age-related midface contour deficiencies in adults aged 22 years or older. Uses unique rheology to adapt to facial movements, providing natural-looking results lasting up to one year. For use by licensed healthcare professionals.
- R-Energy Skin Quality System Comprehensive skin quality approach combining skin boosters (Redensity 1, RHA 1) with advanced dermocosmetics to restore hydration, luminosity, and long-term skin vitality. Works to hydrate, improve elasticity, refine texture, and strengthen skin resilience.
- RHA Deep Repair Balm Post-procedure repair cream for skin recovery following aesthetic treatments. Part of the dermocosmetics product range, sold directly to consumers via the company e-commerce platform and through healthcare professionals for patient recommendations.
Quantifiable outcome
- Products approved and commercialized in 90+ countries worldwide
Companies that use Teoxane Laboratories Geneva
Customer profileSegments2 records
Ideal customer profiles2 records
Teoxane Laboratories Geneva technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Teoxane Laboratories Geneva partnerships and signals
Strategic signalPartnerships
One partnership is on record.
Scale indicators3 records
Recent moves8 records
Expansion highlights6 records
Teoxane Laboratories Geneva competitors and assessment
Company assessmentBroad incumbents
- Galderma: Galderma is the global leader in dermatology aesthetics and the maker of Restylane, the largest HA dermal filler franchise directly competing with Teoxane's TEOSYAL RHA line. Both companies target the same HCP channel (dermatologists, plastic surgeons, aesthetic physicians) with comparable injectable HA products.
- AbbVie (Allergan Aesthetics): AbbVie's Allergan Aesthetics division markets the Juvéderm collection (including Voluma XC, Teoxane's direct benchmark in the RHA Dynamic Volume Phase III trial). Both compete in facial rejuvenation HA fillers sold through HCPs globally.
Direct peers
- Prollenium Medical Technologies: Prollenium manufactures the Revanesse line of HA dermal fillers, directly competing with Teoxane's RHA products in the global aesthetics market with similar technology positioning and HCP go-to-market.
- Merz Aesthetics: Merz Aesthetics markets Belotero Balance (HA filler) and Radiesse (calcium hydroxylapatite), competing directly with Teoxane's RHA and PureSense lines in the medical aesthetics channel. Both are privately-positioned mid-size aesthetics specialists with global distribution.
- Sinclair Pharma: Sinclair Pharma (acquired by Huadong Medicine) markets HA dermal fillers (MaiLi) and complementary aesthetics products, making it a direct competitor to Teoxane in the premium HA filler category globally.
- Revance Therapeutics: Revance is Teoxane's exclusive US distribution partner for the RHA collection and also markets its own DAXI neuromodulator, making it both a channel partner and a competitor in the US medical aesthetics market serving the same HCPs.
- Croma-Pharma: Croma-Pharma is an Austrian family-owned manufacturer of HA-based dermal fillers and skincare, closely comparable to Teoxane as a European mid-size aesthetics specialist with similar product positioning and private ownership structure.
Regional players
- Evolus: Evolus is a US-focused aesthetics company marketing Jeuveau (neuromodulator) and expanding into adjacent categories, competing with Teoxane indirectly for the same HCP aesthetic customer base in North America.
Emerging players
- Hugel (Chaeum, Dermax): Hugel is a Korean aesthetics and botulinum toxin manufacturer that has expanded into HA dermal fillers, competing with Teoxane in the global market with cost-competitive offerings and growing regulatory approvals.
- LG Chem (Yvoire): LG Chem's life sciences division markets Yvoire, a HA dermal filler line, competing with Teoxane in Asian and select global markets as part of a broader conglomerate-backed aesthetics push.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Teoxane Laboratories Geneva social profiles
Digital presenceTeoxane Laboratories Geneva compliance and trust
Trust signalCompliance3 records
Teoxane Laboratories Geneva financial estimates
Financial estimateRevenue estimate
Valuation estimate
Teoxane Laboratories Geneva leadership team
Management profileNumber of profiles
Profiles3 records
Teoxane Laboratories Geneva subsidiaries and ownership
Company hierarchySubsidiaries11 records
Teoxane Laboratories Geneva funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Teoxane Laboratories Geneva M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Teoxane Laboratories Geneva
What does Teoxane Laboratories Geneva do?
Teoxane designs, manufactures, and globally distributes a complete range of hyaluronic acid (HA) dermal fillers under the TEOSYAL PureSense and TEOSYAL RHA product lines, sold as Class III medical devices exclusively to licensed healthcare professionals for facial rejuvenation, wrinkle correction, and volume restoration. The portfolio is complemented by a dermocosmetics skincare range (including RHA Deep Repair Balm and the R-Energy skin quality system) sold both to professionals for patient recommendations and directly to end consumers via the company's e-commerce platform.
Is Teoxane Laboratories Geneva a public or private company?
Teoxane Laboratories Geneva is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Teoxane Laboratories Geneva founded?
Teoxane Laboratories Geneva was founded in 2003. It employs 501 to 1,000 people.
Where is Teoxane Laboratories Geneva based?
Teoxane Laboratories Geneva is headquartered in Geneva, Switzerland, in the Europe region.
How does Teoxane Laboratories Geneva make money?
Two revenue lines are on record. Dermal Filler Product Sales are the primary driver. The others are dermocosmetics Sales.
Who are Teoxane Laboratories Geneva's main competitors?
Broad incumbents on record are Galderma and AbbVie (Allergan Aesthetics). Direct peers are Prollenium Medical Technologies, Merz Aesthetics, Sinclair Pharma, Revance Therapeutics and Croma-Pharma. Evolus is listed as a regional player. Emerging players are Hugel (Chaeum, Dermax) and LG Chem (Yvoire).
Does Teoxane Laboratories Geneva have an API?
No public API is recorded for Teoxane Laboratories Geneva.
What industry is Teoxane Laboratories Geneva in?
Teoxane Laboratories Geneva's product category is Medical Aesthetics. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging). Its NAICS code is 339113 and its SIC code is 2844.